1. Home
  2. CLNN vs STAI Comparison

CLNN vs STAI Comparison

Compare CLNN & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • STAI
  • Stock Information
  • Founded
  • CLNN 2012
  • STAI 2011
  • Country
  • CLNN United States
  • STAI United States
  • Employees
  • CLNN N/A
  • STAI N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • STAI
  • Sector
  • CLNN Health Care
  • STAI
  • Exchange
  • CLNN Nasdaq
  • STAI Nasdaq
  • Market Cap
  • CLNN 23.1M
  • STAI 24.6M
  • IPO Year
  • CLNN N/A
  • STAI N/A
  • Fundamental
  • Price
  • CLNN $4.25
  • STAI $0.78
  • Analyst Decision
  • CLNN Strong Buy
  • STAI
  • Analyst Count
  • CLNN 5
  • STAI 0
  • Target Price
  • CLNN $40.00
  • STAI N/A
  • AVG Volume (30 Days)
  • CLNN 147.3K
  • STAI 958.6K
  • Earning Date
  • CLNN 05-07-2025
  • STAI 01-01-0001
  • Dividend Yield
  • CLNN N/A
  • STAI N/A
  • EPS Growth
  • CLNN N/A
  • STAI N/A
  • EPS
  • CLNN N/A
  • STAI N/A
  • Revenue
  • CLNN $350,000.00
  • STAI $542,166.00
  • Revenue This Year
  • CLNN N/A
  • STAI N/A
  • Revenue Next Year
  • CLNN $1,941.87
  • STAI N/A
  • P/E Ratio
  • CLNN N/A
  • STAI N/A
  • Revenue Growth
  • CLNN N/A
  • STAI N/A
  • 52 Week Low
  • CLNN $2.28
  • STAI $0.68
  • 52 Week High
  • CLNN $9.20
  • STAI $9.07
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 64.94
  • STAI N/A
  • Support Level
  • CLNN $2.28
  • STAI N/A
  • Resistance Level
  • CLNN $4.49
  • STAI N/A
  • Average True Range (ATR)
  • CLNN 0.43
  • STAI 0.00
  • MACD
  • CLNN 0.21
  • STAI 0.00
  • Stochastic Oscillator
  • CLNN 73.78
  • STAI 0.00

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About STAI ScanTech AI Systems Inc. Common stock

ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.

Share on Social Networks: